Clinical trial
Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease
NCT05509387 is registered in ClinicalTrials.gov with Baycrest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating if a Stronger tDCS Intensity is More Effective for Improving Naming Ability in People Living With Alzheimer's Disease
- Lead sponsor
- Baycrest
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- December 31, 2026
- Enrollment
- 42 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.